Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger protein 700 (ZNF700) is a member of the C2H2-type zinc finger family, the largest group of human transcription factors, characterized by tandem C2H2 zinc finger domains that bind DNA and regulate gene expression[4][5]. ZNF700 is classified as a classical C2H2 zinc finger protein, containing multiple C2H2 repeats that facilitate sequence-specific DNA binding and transcriptional modulation[5][7]. Although the precise biological function of ZNF700 is not comprehensively described in the literature, it is known to be immunogenic and has been identified as a target of autoantibodies in patients with colorectal cancer, supporting its potential utility as a minimally invasive biomarker for disease detection[7]. Beyond this, ZNF700 shares the general roles of zinc finger proteins, which include regulating gene expression, influencing cell differentiation, and contributing to genome stability[1][3][5]. There is no compelling evidence that ZNF700 serves as a direct therapeutic target (such as a receptor or enzyme), nor are there any approved drugs known to specifically interact with it.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger protein 700 (ZNF700).